Skip to main content

Table 3 Dietary intake of METABO and placebo groups from week 0 through week 8 using 3-day food records

From: Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women

Variable METABO Placebo P
n = 27 n = 18 Value1
(Baseline) Pre-intervention Mid point End of study (Baseline) Pre-intervention Mid point End of study  
  (Week 0) (Week 4) (Week 8) (Week 0) (Week 4) (Week 8)  
Energy (kcal/d) 1831 ± 491 1889 ± 428 1912 ± 423 1764 ± 482 1913 ± 432 1917 ± 479 0.48, 0.41
Carbohydrate (g/d) 206 ± 78 188 ± 58 188 ± 57 215 ± 94 191 ± 58 202 ± 61 0.94, 0.80
Carbohydrate (%) 46 ± 14 39 ± 6 39 ± 5 48 ± 15 40 ± 6 42 ± 5 0.70, 0.90
Fat (g/d) 54 ± 20 56 ± 17 57 ± 15 52 ± 23 57 ± 13 56 ± 13 0.87, 0.85
Fat (%) 26 ± 7 27 ± 4 27 ± 4 27 ± 10 27 ± 4 27 ± 4 0.98, 0.79
Protein (g/d) 130 ± 66 158 ± 43 162 ± 47 110 ± 50 161 ± 47 150 ± 50 0.77, 0.66
Protein (%) 28 ± 12 34 ± 8 34 ± 7 26 ± 13 34 ± 7 31 ± 6 0.52, 0.99
  1. Values are mean ± SD.
  2. 1P values are for the differences between the two groups, METABO versus placebo at week 4 and week 8, respectively. No significant between group differences at week 4 or week 8 time points were noted using ANCOVA (where the week 0 time points were used as the covariate). Target dietary intake was provided to each subject after baseline 3-day food records (pre-intervention) using the Mifflin-St. Jeor equation plus an activity factor of 1.2 minus 500 kcal/day, with a macronutrient ratio of 40% carbohydrate, 30% fat and 30% protein.